Brazil authorizes purchase of medicinal products that are cannabis-based
ANVISA authorized brand new laws for the roll-out of medicinal items produced by cannabis
The Brazilian Health Regulatory Agency (ANVISA) authorized, at the start of 2019, regulations that allow the sale in pharmacies of cannabis-based products for medical purposes december. The procedures for manufacturing and importing such products and the requirements for prescription, sale, and supervision are approved in these new proposals. Authorization will not consist of substance managing in pharmacies and it is just permitted to offer – by prescription – services and products currently developed directly through the maker. The approved guidelines will continue to be in force for three years, after which it a brand new standard will likely be released, taking into consideration the outcomes acquired in this initial duration. Read more →